Immuneering Corp. (IMRX)
5.035
+0.14
(+2.97%)
USD |
NASDAQ |
May 20, 16:00
5.035
0.00 (0.00%)
After-Hours: 20:00
Immuneering Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| X4 Pharmaceuticals, Inc. | -747.5% |
| vTv Therapeutics, Inc. | 65.51% |
| Design Therapeutics, Inc. | -- |
| Tango Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.61% |
| Return on Assets | -34.96% |
| Return on Invested Capital | -36.62% |
| Return on Net Operating Assets | -478.2% |